GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Medivation Inc. (MDVN) Sr. Vice President and CFO Clarence Patrick Machado sells 20,000 Shares

December 08, 2009 | About:
10qk

insider

56 followers
Sr. Vice President and CFO of Medivation Inc. (MDVN) Clarence Patrick Machado sells 20,000 shares of MDVN on 12/07/2009 at an average price of $33.27 a share.

Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. Medivation's current portfolio consists of small molecule drugs in development to treat three large, unmet medical needs Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. The Company intends to build and maintain a portfolio of four to six development programs at all times. The Company had built a portfolio of innovative medical technologies and a team of employees and seasoned consultants with significant expertise in the identification, evaluation, acquisition, development and sale/partnering of small molecule therapeutics, biotechnology products and medical devices Medivation Inc. has a market cap of $1.11 billion; its shares were traded at around $33.25 with and P/S ratio of 88.6.

MDVN is in the portfolios of George Soros of Soros Fund Management LLC.

Insiders' Positions with MDVN



  • Sell:: President and CEO David Hung sold 25,000 shares of MDVN stock on 09/10/2009 at the average price of 25.84, the price of the stock has increased by 28.68% since
  • Sell:: President and CEO David Hung sold 25,000 shares of MDVN stock on 07/01/2009 at the average price of 22.62, the price of the stock has increased by 46.99% since


Insiders' Positions with MDVN



  • Sell:: Sr. Vice President and CFO Clarence Patrick Machado sold 20,000 shares of MDVN stock on 11/11/2009 at the average price of 28.28, the price of the stock has increased by 17.57% since
  • Sell:: Sr. Vice President and CFO Clarence Patrick Machado sold 20,000 shares of MDVN stock on 09/10/2009 at the average price of 25.86, the price of the stock has increased by 28.58% since
  • Sell:: Sr. Vice President and CFO Clarence Patrick Machado sold 20,000 shares of MDVN stock on 07/01/2009 at the average price of 22.48, the price of the stock has increased by 47.91% since


Insiders' Positions with MDVN



  • Sell:: Director Gregory Bailey sold 10,000 shares of MDVN stock on 12/01/2009 at the average price of 31.49, the price of the stock has increased by 5.59% since
  • Sell:: Director Gregory Bailey sold 14,000 shares of MDVN stock on 11/20/2009 at the average price of 25.99, the price of the stock has increased by 27.93% since
  • Sell:: Director Gregory Bailey sold 14,000 shares of MDVN stock on 11/20/2009 at the average price of 29, the price of the stock has increased by 14.66% since
  • Sell:: Director Gregory Bailey sold 10,000 shares of MDVN stock on 09/14/2009 at the average price of 25.99, the price of the stock has increased by 27.93% since
  • Sell:: Chief Medical Officer Lynn Seely sold 18,000 shares of MDVN stock on 09/10/2009 at the average price of 25.87, the price of the stock has increased by 28.53% since


About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.0/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide